Menarini Group
Stemline Therapeutics, a Menarini Group company headquartered in New York City, is a commercial-stage biopharmaceutical company focused on developing and commercializing novel oncology therapeutics. Founded by Dr. Ivan Bergstein in 2003, the company aims to improve the lives of cancer patients with first-in-class treatments. Its FDA-approved product ELZONRIS (tagraxofusp), a CD123-directed therapy, treats blastic plasmacytoid dendritic cell neoplasm, and its pipeline includes ELZONRIS, SL-701 and SL-801 for various cancers.
Recently Posted Jobs at Menarini Group
Menarini Group Offices
Hybrid Workspace
Employees engage in a combination of remote and on-site work.
Typical time on-site:
